無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

画像誘導インターベンション装置の世界市場の将来予測

Global Interventional Image-guided System Market Forecast 2019-2027

発行 Inkwood Research 商品コード 748434
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
画像誘導インターベンション装置の世界市場の将来予測 Global Interventional Image-guided System Market Forecast 2019-2027
出版日: 2018年11月22日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の画像誘導インターベンション装置の市場の将来展望について分析し、システムの概要や市場の構造、主な市場促進・抑制要因、全体的な市場規模の動向見通し (今後9年間分)、種類別・モダリティ別・用途別・エンドユーザー別および地域別の詳細動向、関連産業との連関構造と市場機会、市場競争環境、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の範囲と定義
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 製品別の市場

  • シングルプレーン
  • バイプレーン・システム

第6章 種類別の市場

  • CT (コンピューター断層診断)
  • X線透視撮影
  • MRI (核磁気共鳴画像)
  • PET (ポジトロン放出断層撮影)
  • 超音波
  • 内視鏡
  • SPECT (単光子放出コンピュータ断層撮影)

第7章 モダリティ別の市場

  • 血管インターベンション装置
  • IVUS (血管内超音波検査)、FFR (冠動脈血流予備量比)、IFR (瞬時血流予備量比)
  • 術中超音波スキャナ
  • 透視撮影
  • 術中CTスキャナ
  • 内視鏡装置
  • 術中MRIスキャナ
  • その他

第8章 用途別の市場

  • 心臓疾患
  • 神経症
  • 腫瘍
  • 胃腸疾患
  • 整形外科
  • 耳鼻咽喉科 (ENT) 手術
  • その他

第9章 エンドユーザー別の市場

  • 病院
  • 日帰り手術センター (ASC)
  • 専門クリニック

第10章 主要指標

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制体制:世界各国の事例
  • 監督官庁/業界団体
  • 市場機会マトリックス

第11章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランス、スペイン、イタリアなど)
  • アジア太平洋地域 (中国、インド、日本、オーストラリア、韓国など)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第12章 競争環境

  • 市場シェア分析
  • 企業プロファイル
    • ARTHREX
      • 企業概要
      • 製品ポートフォリオ
      • SCOT分析
      • 戦略展開状況
    • B.BRAUN MELSUNGEN AG
    • BOSTON SCIENTIFIC CORPORATION
    • キヤノン
    • C. R. BARD, INC.
    • DENTSPLY SIRONA INC.
    • ELEKTA AB
    • 富士フイルムホールディングス
    • GE HEALTHCARE
    • 日立メディコ
    • HOLOGIC, INC.
    • KARL STORZ GMBH & CO. KG
    • KONINKLIJKE PHILIPS N.V.
    • MEDTRONIC PLC
    • オリンパス
    • SIEMENS AG
    • STRYKER CORPORATION
    • テルモ
図表

LIST OF TABLES

  • TABLE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
  • TABLE 2 CORONARY AND PROCEDURE REIMBURSEMENT BY MEDICARE IN ASCS
  • TABLE 3 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PRODUCTS 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MODALITY 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9 NORTH AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 10 EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 11 ASIA PACIFIC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 12 REST OF WORLD INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TECHNOLOGY 2017 & 2027 (%)
  • FIGURE 3 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
  • FIGURE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SINGLE PLANE 2019-2027 ($ MILLION)
  • FIGURE 5 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
  • FIGURE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY BI-PLANE SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TYPES 2017 & 2027 (%)
  • FIGURE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY X-RAY FLUOROSCOPY IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MRI IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PET IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ULTRASOUND IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPE IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY MODALITY 2017 & 2027 (%)
  • FIGURE 16 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY VASCULAR INTERVENTIONAL SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY IVUS, FFR, IFR 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE ULTRASOUND SCANNER 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY FLUOROSCOPY 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE CT SCANNER 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPES SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE MRI SCANNER 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER MODALITY 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
  • FIGURE 25 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CARDIOLOGY 2019-2027 ($ MILLION)
  • FIGURE 26 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY NEUROLOGY 2019-2027 ($ MILLION)
  • FIGURE 27 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
  • FIGURE 28 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GASTROENTEROLOGY 2019-2027 ($ MILLION)
  • FIGURE 29 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ORTHOPEDICS 2019-2027 ($ MILLION)
  • FIGURE 30 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENT SURGERY 2019-2027 ($ MILLION)
  • FIGURE 31 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
  • FIGURE 32 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
  • FIGURE 33 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY HOSPITALS 2019-2027 ($ MILLION)
  • FIGURE 34 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 35 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECIALTY CLINICS 2019-2027 ($ MILLION)
  • FIGURE 36 PORTER'S FIVE FORCE MODEL
  • FIGURE 37 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 38 THE UNITED STATES INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 CANADA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 GERMANY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 THE UNITED KINGDOM INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 FRANCE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 SPAIN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 ITALY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 REST OF EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 CHINA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 INDIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 48 JAPAN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 49 AUSTRALIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 50 SOUTH KOREA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 51 REST OF APAC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 52 LATIN AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 53 MIDDLE EAST AND AFRICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
  • FIGURE 54 INTERVENTIONAL IMAGE GUIDED SYSTEM COMPANY MARKET SHARE 2017 (%)
目次
Product Code: 22639

KEY FINDINGS

The leading industry of the health care sector is that of the medical devices which are highly dynamic mainly because of product launches in the active fields of imaging, diagnostics and therapeutics. Pre-surgical and surgical interventions are heavily dependent on the imaging system for their maximum efficiency and patient's accurate diagnosis. The image-guided intervention market is on the verge of positive growth owing to the need for a high precision system to guide in the most critical surgical procedure. The global image-guided intervention market is progressing at a CAGR of 5.08% during the forecast years.

MARKET INSIGHTS

Cost-containment measures to reduce the healthcare burden, especially in developed economies are adopted by the respective governments, healthcare providers, insurance payers and life sciences companies to aid maximum value for money spent on healthcare and achieve better health outcomes. This factor is mainly driving the industry globally. Though this technology is vital to clinical diagnosis and treatment, the risk of radiation exposure in interventional cardiology procedures such as coronary angiography and left ventriculography cannot be overlooked.

REGIONAL INSIGHTS

The global market for image-guided intervention is geographically segmented into different regions like North America, Europe, Asia Pacific and the Rest of the World to gain further market insights for analysis. The region of North America is found to hold the largest market share for image-guided intervention globally. Rising number of healthcare services coupled with rising healthcare expenditure and customer affordability is expected to drive this humongous market in the North American region.

Different government bodies in different regions regulate the approval and sales of medical devices that can restrict market growth.

COMPETITIVE INSIGHTS

The global market leaders are leveraging on their strong business segment and are launching various new modalities to gain an edge over the other. Some of these market players are Arthrex, B. Braun Melsungen AG, Boston Scientific Corporation, Canon Inc., C.R. Bard, Inc., Dentsply Sirona Inc., Elekta AB, Fujifilm Holdings Corporation and GE Healthcare.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SINGLE PLANE PRODUCTS HOLD THE LARGEST MARKET SHARE
    • 3.2.2. IVUS, FFR, IFR ARE ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD IN TERMS OF MODALITY
    • 3.2.3. CARDIOLOGY IS THE WIDELY USED APPLICATION
    • 3.2.4. SPECIALTY CLINICS ARE THE FASTEST GROWING END USER

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. SHIFTING FOCUS FROM VOLUME-BASED TO VALUE-BASED SYSTEM
    • 4.2.2. DEVELOPING EMERGING MARKETS
    • 4.2.3. GROWING DEMAND FOR IMAGING TECHNOLOGY
    • 4.2.4. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
    • 4.2.5. RISING DEMAND FOR INTERVENTIONAL IMAGING IN FRACTURES AND TRAUMATIC INJURIES
    • 4.2.6. FAVORABLE REIMBURSEMENT SCENARIOS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF HYBRID OPERATING ROOM EQUIPMENT
    • 4.3.2. LIMITATIONS IN INTERVENTIONAL IMAGE-GUIDED SYSTEMS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. ACCEPTANCE OF HYBRID IMAGING AMONG END USERS
    • 4.4.2. OUTSOURCING OF SOLUTION FOR SURGICAL THEATERS PROVIDING QUALITY IMAGING TO THE SURGEONS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. REAL-TIME IMAGING CHALLENGES

5. MARKET BY PRODUCTS

  • 5.1. SINGLE PLANE
  • 5.2. BI-PLANE SYSTEMS

6. MARKET BY TYPES

  • 6.1. CT IMAGE-GUIDED SYSTEMS
  • 6.2. X-RAY FLUOROSCOPY IMAGE-GUIDED SYSTEMS
  • 6.3. MRI IMAGE-GUIDED SYSTEMS
  • 6.4. PET IMAGE-GUIDED SYSTEMS
  • 6.5. ULTRASOUND IMAGE-GUIDED SYSTEMS
  • 6.6. ENDOSCOPE IMAGE-GUIDED SYSTEMS
  • 6.7. SPECT IMAGE-GUIDED SYSTEMS

7. MARKET BY MODALITY

  • 7.1. VASCULAR INTERVENTIONAL SYSTEMS
  • 7.2. IVUS, FFR, IFR
  • 7.3. INTRAOPERATIVE ULTRASOUND SCANNER
  • 7.4. FLUOROSCOPY
  • 7.5. INTRAOPERATIVE CT SCANNER
  • 7.6. ENDOSCOPES SYSTEMS
  • 7.7. INTRAOPERATIVE MRI SCANNER
  • 7.8. OTHER MODALITY

8. MARKET BY APPLICATION

  • 8.1. CARDIOLOGY
  • 8.2. NEUROLOGY
  • 8.3. ONCOLOGY
  • 8.4. GASTROENTEROLOGY
  • 8.5. ORTHOPEDICS
  • 8.6. ENT SURGERY
  • 8.7. OTHER APPLICATIONS

9. MARKET BY END USER

  • 9.1. HOSPITALS
  • 9.2. AMBULATORY SURGICAL CENTERS
  • 9.3. SPECIALTY CLINICS

10. KEY ANALYTICS

  • 10.1. PORTERS FIVE FORCES ANALYSIS
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE
    • 10.1.3. BARGAINING POWER OF SUPPLIERS
    • 10.1.4. BARGAINING POWER OF BUYERS
    • 10.1.5. THREAT OF COMPETITIVE RIVALRY
  • 10.2. SUPPLY CHAIN ANALYSIS
  • 10.3. REGULATORY FRAMEWORK
    • 10.3.1. NORTH AMERICA MEDICAL DEVICE REGULATIONS
    • 10.3.2. EUROPE MEDICAL DEVICE REGULATIONS
    • 10.3.3. ASIA-PACIFIC MEDICAL DEVICE REGULATIONS
    • 10.3.4. LATIN AMERICA MEDICAL DEVICE REGULATIONS
    • 10.3.5. MIDDLE EAST AND AFRICA MEDICAL DEVICE REGULATIONS
  • 10.4. REGULATORY BODIES
  • 10.5. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE UNITED STATES
    • 11.1.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. GERMANY
    • 11.2.2. THE UNITED KINGDOM
    • 11.2.3. FRANCE
    • 11.2.4. SPAIN
    • 11.2.5. ITALY
    • 11.2.6. REST OF EUROPE
  • 11.3. ASIA PACIFIC
    • 11.3.1. CHINA
    • 11.3.2. INDIA
    • 11.3.3. JAPAN
    • 11.3.4. AUSTRALIA
    • 11.3.5. SOUTH KOREA
    • 11.3.6. REST OF APAC
  • 11.4. REST OF WORLD
    • 11.4.1. LATIN AMERICA
    • 11.4.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILE
    • 12.2.1. ARTHREX
      • 12.2.1.1. COMPANY OVERVIEW
      • 12.2.1.2. PRODUCT PORTFOLIO
      • 12.2.1.3. SCOT ANALYSIS
      • 12.2.1.4. STRATEGIC MOVES
    • 12.2.2. B.BRAUN MELSUNGEN AG
      • 12.2.2.1. OVERVIEW
      • 12.2.2.2. PRODUCT PORTFOLIO
      • 12.2.2.3. SCOT ANALYSIS
      • 12.2.2.4. STRATEGIC ANALYSIS
    • 12.2.3. BOSTON SCIENTIFIC CORPORATION
      • 12.2.3.1. COMPANY OVERVIEW
      • 12.2.3.2. PRODUCT PORTFOLIO
      • 12.2.3.3. SCOT ANALYSIS
      • 12.2.3.4. STRATEGIC INITIATIVES
    • 12.2.4. CANON INC.
      • 12.2.4.1. COMPANY OVERVIEW
      • 12.2.4.2. PRODUCT PORTFOLIO
      • 12.2.4.3. SCOT ANALYSIS
      • 12.2.4.4. STRATEGIC INITIATIVES
    • 12.2.5. C. R. BARD, INC.
      • 12.2.5.1. COMPANY OVERVIEW
      • 12.2.5.2. PRODUCT PORTFOLIO
      • 12.2.5.3. SCOT ANALYSIS
      • 12.2.5.4. STRATEGIC INITIATIVES
    • 12.2.6. DENTSPLY SIRONA INC.
      • 12.2.6.1. COMPANY OVERVIEW
      • 12.2.6.2. SCOT ANALYSIS
      • 12.2.6.3. PRODUCT PORTFOLIO
      • 12.2.6.4. STRATEGIC INITIATIVES
    • 12.2.7. ELEKTA AB
      • 12.2.7.1. COMPANY OVERVIEW
      • 12.2.7.2. PRODUCT PORTFOLIO
      • 12.2.7.3. SCOT ANALYSIS
      • 12.2.7.4. STRATEGIC INITIATIVES
    • 12.2.8. FUJIFILM HOLDINGS CORPORATION
      • 12.2.8.1. COMPANY OVERVIEW
      • 12.2.8.2. PRODUCT PORTFOLIO
      • 12.2.8.3. SCOT ANALYSIS
      • 12.2.8.4. STRATEGIC INITIATIVES
    • 12.2.9. GE HEALTHCARE
      • 12.2.9.1. COMPANY OVERVIEW
      • 12.2.9.2. PRODUCT PORTFOLIO
      • 12.2.9.3. SCOT ANALYSIS
      • 12.2.9.4. STRATEGIC INITIATIVES
    • 12.2.10. HITACHI MEDICAL CORPORATION
      • 12.2.10.1. COMPANY OVERVIEW
      • 12.2.10.2. PRODUCT PORTFOLIO
      • 12.2.10.3. SCOT ANALYSIS
      • 12.2.10.4. STRATEGIC INITIATIVES
    • 12.2.11. HOLOGIC, INC.
      • 12.2.11.1. COMPANY OVERVIEW
      • 12.2.11.2. PRODUCT PORTFOLIO
      • 12.2.11.3. SCOT ANALYSIS
      • 12.2.11.4. STRATEGIC INITIATIVES
    • 12.2.12. KARL STORZ GMBH & CO. KG
      • 12.2.12.1. COMPANY OVERVIEW
      • 12.2.12.2. PRODUCT PORTFOLIO
      • 12.2.12.3. SCOT ANALYSIS
      • 12.2.12.4. STRATEGIC INITIATIVES
    • 12.2.13. KONINKLIJKE PHILIPS N.V.
      • 12.2.13.1. COMPANY OVERVIEW
      • 12.2.13.2. PRODUCT PORTFOLIO
      • 12.2.13.3. SCOT ANALYSIS
      • 12.2.13.4. STRATEGIC INITIATIVES
    • 12.2.14. MEDTRONIC PLC
      • 12.2.14.1. COMPANY OVERVIEW
      • 12.2.14.2. PRODUCT PORTFOLIO
      • 12.2.14.3. SCOT ANALYSIS
      • 12.2.14.4. STRATEGIC INITIATIVES
    • 12.2.15. OLYMPUS CORPORATION
      • 12.2.15.1. COMPANY OVERVIEW
      • 12.2.15.2. PRODUCT PORTFOLIO
      • 12.2.15.3. SCOT ANALYSIS
      • 12.2.15.4. STRATEGIC INITIATIVES
    • 12.2.16. SIEMENS AG
      • 12.2.16.1. COMPANY OVERVIEW
      • 12.2.16.2. PRODUCT PORTFOLIO
      • 12.2.16.3. SCOT ANALYSIS
      • 12.2.16.4. STRATEGIC INITIATIVES
    • 12.2.17. STRYKER CORPORATION
      • 12.2.17.1. COMPANY OVERVIEW
      • 12.2.17.2. PRODUCT PORTFOLIO
      • 12.2.17.3. SCOT ANALYSIS
      • 12.2.17.4. STRATEGIC INITIATIVES
    • 12.2.18. TERUMO CORPORATION
      • 12.2.18.1. COMPANY OVERVIEW
      • 12.2.18.2. PRODUCT PORTFOLIO
      • 12.2.18.3. SCOT ANALYSIS
      • 12.2.18.4. STRATEGIC INITIATIVE
Back to Top